CLINICAL_TRIALS
trial_result
· 2024-01-16
Clinical Trial Update: A Dose-ranging Pediatric Study of an Adjuvanted Pandemic Influenza Vaccine [Phase 2]
Summary
Phase 2 dose-ranging pediatric trial of an adjuvanted pandemic influenza vaccine completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Seqirus | Conditions: Influenza, Human | Phase 2 | Status: COMPLETED | Results posted: 2024-01-16